Cheguo Cai

ORCID: 0000-0002-3712-1696 · 1 paper in corpus

lab-animal 2022

Interleukin-18-Primed Human Umbilical Cord-Mesenchymal Stem Cells Achieve Superior Therapeutic Efficacy for Severe Viral Pneumonia Via Enhancing T-Cell Immunosuppression

·doi:10.2139/ssrn.4191376

Background: Coronavirus disease 2019 (COVID-19) treatments are still urgently needed for critically and severely ill patients. Human umbilical cord-mesenchymal stem cells (hUC-MSCs) infusion has therapeutic benefits in COVID-19 patients; ho…